Skip to content

Clinical trials

Carcinoma, Medullary trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Medullary Country / region: Italy Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20062
20081
20111
20122
20131
20142
20151
20172
20191
20201
20221
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Active, not recruiting4
Unknown status2
Approved for marketing1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company3
Genzyme, a Sanofi Company3
Exelixis2
Fondazione Policlinico Universitario Agostino Gemelli IRCCS2
Sanofi2
Aristotle University Of Thessaloniki1
European Organisation for Research and Treatment of Cancer - EORTC1
Federico II University1
Hoffmann-La Roche1
IRCCS Azienda Ospedaliero-Universitaria di Bologna1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Medullary19
Thyroid Neoplasms11
Thyroid Cancer, Papillary6
Carcinoma, Non-Small-Cell Lung4
Colonic Neoplasms4
Breast Neoplasms3
Bronchial Neoplasms3
Carcinoma, Bronchogenic3
Endocrine Gland Neoplasms3
Endocrine System Diseases3

Trials

Showing 51 to 19 of 19. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.